ResearchOxford Medical Case Reports
I cannot picture it in my mind: acquired aphantasia after autologous stem cell transplantation for multiple myeloma
Bumgardner, Yuan and ChiuApril 2021
Abstract
Aphantasia, the loss of mental imagery, is a rare disorder and even more infrequent when acquired. No previous cases have been identified that were caused by transplant-related treatment. We describe a case of acquired aphantasia in a 62-year-old male with refractory IgG kappa multiple myeloma after receiving an autologous stem cell transplant (ASCT) following high-dose melphalan with a complicated hospital admission. The etiology of aphantasia remains unidentified, but we provide viable explanations to include direct effects from ASCT treatment and indirect effects from transplant-related complications.
Our summary in plain words
What This Study Is About
How They Studied It
What They Found
What This Might Mean
One Interesting Detail
This summary was written with AI and may contain errors. Check the original paper.
Authors
Adam L Bumgardner
Internal Medicine and Psychiatry Residency Program, National Capital Consortium, Bethesda, MD, USA
1 paper in the libraryKyle Yuan
F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
1 paper in the libraryAlden V Chiu
Hematology-Oncology Service, Walter Reed National Military Medical Center, Bethesda, MD, USA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
1 paper in the library
Cite this paper
Bumgardner, A. L., Yuan, K., & Chiu, A. V. (2021). I cannot picture it in my mind: acquired aphantasia after autologous stem cell transplantation for multiple myeloma. Oxford Medical Case Reports, 2021(5). doi:10.1093/omcr/omab019
Topics
Most-cited researchers
Recruit participants for your study
We can help you reach people across the imagery spectrum, from aphantasia to hyperphantasia.
Partner with usImage-Free Insights
A short note from our founder, Tom Ebeyer, every other week, plus occasional news and invitations to take part in studies. Change what you get from any email.